Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS: AMPE · Delayed Price · USD
0.350
0.00 (0.00%)
Apr 26, 2024, 9:30 AM EDT - Market open

Ampio Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2006
Net Income
-8.63-8.47-12.49-16.5-8.6833.99-51.89-19.16-32.01-38.13
Upgrade
Depreciation & Amortization
0.121.051.091.181.271.281.211.211.140.44
Upgrade
Share-Based Compensation
0.160.952.721.280.410.440.741.526.177.85
Upgrade
Other Operating Activities
-0.21-14.66-5.42-0.69-8.38-47.8538.521.81-1.74-0.91
Upgrade
Operating Cash Flow
-8.56-21.13-14.09-14.73-15.38-12.14-11.41-14.62-26.44-30.74
Upgrade
Capital Expenditures
00-0.1-0.06-0.02-0.56-0.07-0.01-0.24-8.67
Upgrade
Acquisitions
00000000-1.540
Upgrade
Other Investing Activities
---------00.01
Upgrade
Investing Cash Flow
00-0.1-0.06-0.02-0.56-0.07-0.01-1.78-8.66
Upgrade
Common Stock Issued
0.1-0.0333.0126.1912.14813.343.90.0368.41
Upgrade
Share Repurchases
0-0-0.190000000
Upgrade
Other Financing Activities
--0.08-2.47-0.592.214.081.45-0.384.83-5
Upgrade
Financing Cash Flow
0.1-0.1130.7325.6114.3512.0814.793.534.8663.41
Upgrade
Net Cash Flow
-8.56-21.2416.5510.81-1.05-0.623.31-11.1-23.3624.01
Upgrade
Free Cash Flow
-8.56-21.13-14.19-14.79-15.41-12.7-11.48-14.63-26.68-39.41
Upgrade
Free Cash Flow Margin
---------2295.11%-51322.40%
Upgrade
Free Cash Flow Per Share
-10.57-28.04-21.13-24.84-32.50-33.04-2.64-4.08-153.95-235.39
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.